STC
AMGN icon

Sarah T. Connolly’s Amgen AMGN Stock Holding History

Sarah T. Connolly’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,150
Closed -$309K – 11
2023
Q3 		$309K Sell
1,150
-75
-6% -$18.7K 0.2% 78
2023
Q2 		$272K Hold
1,225
– – 0.16% 85
2023
Q1 		$296K Sell
1,225
-65
-5% -$16K 0.19% 82
2022
Q4 		$339K Sell
1,290
-80
-6% -$21.4K 0.23% 81
2022
Q3 		$309K Sell
1,370
-40
-3% -$9.7K 0.23% 86
2022
Q2 		$343K Sell
1,410
-70
-5% -$17.2K 0.23% 80
2022
Q1 		$358K Hold
1,480
– – 0.21% 80
2021
Q4 		$333K Buy
1,480
+5
+0.3% +$1.05K 0.19% 81
2021
Q3 		$314K Hold
1,475
– – 0.26% 84
2021
Q2 		$360K Hold
1,475
– – 0.29% 77
2021
Q1 		$367K Hold
1,475
– – 0.33% 78
2020
Q4 		$339K Buy
+1,475
New +$340K 0.31% 78

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sarah T. Connolly's AMGN Position: Q4 2023 in Review

Sarah T. Connolly sold out of Amgen (AMGN) in Q4 2023, closing a stake of 1,150 shares — an estimated $309K sold.

Sarah T. Connolly first reported a position in AMGN in Q4 2020 and held it in 12 quarters. The position peaked at $367K in Q1 2021. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

  • Sarah T. Connolly reported no remaining Amgen position as of Q4 2023 after selling out during the quarter.
  • Sarah T. Connolly sold 1,150 Amgen shares in Q4 2023, an estimated $309K.
  • Sarah T. Connolly first reported a position in Amgen in Q4 2020 and held it in 12 quarters.
  • Sarah T. Connolly's Amgen position peaked at $367K in Q1 2021.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on Sarah T. Connolly's 13F filing for Q4 2023, filed 9 Feb 2024.